Evidence map›Paper›PMID 37788791›Full record

ArticleJournal of pharmaceutical sciences2024

Developing a Modular Continuous Drug Product Manufacturing System with Real Time Quality Assurance for Producing Pharmaceutical Mini-Tablets.

Varun Sundarkumar, Wanning Wang, Madeline Mills, Sue Wei Oh, Zoltan Nagy, Gintaras Reklaitis

Abstract read
In one paragraph

Article in Journal of pharmaceutical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Varun SundarkumarDavidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA. Electronic address: vsundark@purdue.edu.
Wanning WangDavidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA.
Madeline MillsDavidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA.
Sue Wei OhDavidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA.
Zoltan NagyDavidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA.
Gintaras ReklaitisDavidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA.

Funding

Risk-based process synthesis and Industry 4.0 framework for pharmaceutical manufacturing processesU01FD006738 · FDA · PURDUE UNIVERSITY · PI NAGY, ZOLTAN KALMAN · 2019 to 2021
$3.0M
FDA HHS U01 FD006738
6 · The paper itself

Abstract

The pharmaceutical industry has shown keen interest in developing small-scale modular manufacturing systems for producing medicinal products. These systems offer agile and flexible manufacturing, and are well-suited for use in situations requiring rapid production of drugs such as pandemics and humanitarian disasters. The creation of such systems requires the development of modular facilities for making solid oral drug products. In recent years, however, the development of such facilities has seen limited progress. This study presents a development of a prototype modular system that uses drop on demand (DoD) printing to produce personalized solid oral drug products. The system's operation is demonstrated for manufacturing mini-tablets, a category of pediatric drug products, in continuous and semi-batch modes. In this process, the DoD printer is used to generate molten formulation drops that are solidified into mini-tablets. These dosages are then extracted, washed and dried in a continuous filtration and drying unit which is integrated with the printer. Process monitoring tools are also incorporated in the system to track the critical quality attributes of the product and the critical process parameters of the manufacturing operation in real time. Future areas of innovation are also proposed to improve this prototype unit and to enable the development of advanced drug manufacturing systems based on this platform.

Indexed as

Drug IndustryTechnology, PharmaceuticalChildHumansPharmaceutical PreparationsTabletsPharmaceutical PreparationsTablets3D printingContinuous manufacturingModularizationPharmaceutical mini-tabletsReal time monitoring

Identifiers

PMID37788791
PMCPMC10947937

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.